Many biologic drugs, such as antibodies and proteins, and vaccines are produced through the large-scale culturing of mammalian cells. From R&D through screening and production, bioprocess cell culturing must be carefully monitored and regulated to optimize growth conditions, control feeding and prevent contamination. To do so, genetic, physical and environmental parameters are continuously tested. Environmental […]

One of the enduring features of the analytical and life science instrument industry is its steadfastness. Although sales ebb and flow based on changes in applications and market requirements, they seldom exhibit significant year-to-year fluctuations. Unfortunately, 2009 appears to be a glaring exception. In January, when the 2009 IBO forecast issue was researched and published […]

Surface Measurement Systems (SMS) has provided instruments, chiefly dynamic vapor sorption systems, for solids characterization, including powders and fibers, for 18 years. Dr. Nishil Malde, International product manager at SMS told IBO, “SMS coined the phrase ‘Dynamic Vapour Sorption’ (DVS). We were the first company to develop and manufacture the first commercial, fully automated DVS […]

Two companies in IBO’s Laboratory Instrument Sales Index reported fiscal year-end March 31 results after the publication of the 2008 and first-quarter Index numbers (see IBO 2/15/09, 4/30/09, 5/15/09). Including year-end results for Shimadzu and Oxford Instruments (Analytical), Index revenues rose 12.1% in 2008 and operating profits increased 14.5%. For the first quarter, Index sales […]

First-quarter revenues for the IBO Lab Equipment/Consumables Index declined 9.9% to $803.18 million and operating profits fell 9.8% to $245.35 million, while operating margin was unchanged at 30.5% of sales. Unfavorable currency transactions for US companies and reduced R&D spending by customers resulted in lower revenue growth. Biohit Oyj’s first-quarter sales grew 2.0% to €8.3 […]

The growing volume and complexity of genomic research requires higher-throughput, higher-density techniques that can simultaneously capture multiple data points with greater sensitivity at a lower cost per point. Rare variant research, validation studies and biomarker discovery are among the applications that will directly benefit. Such advancements are also applicable to the development and application of […]

The March 31 issue of IBO outlined specific projects funded by the EU’s €50 billion ($69.9 billion) research support mechanism, the Seventh Framework Program (FP7). The Innovative Medicines Initiative (IMI), one of the six Joint Technology Initiatives in the Cooperation thematic subgroup of the FP7, awarded €236 million ($329.9 million) for its first call for […]